Skip to content
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move into the mid-year, the […]
Q1 roundup of state health policy impacting biotech Read More »
Agricultural legislative activity is proving to be busy this year for biotech as we move out of Q1 and into the summer. GMO labeling,
Q1 roundup of state ag policy impacting biotech Read More »
Colorado’s contributions to biotechnology innovation—and biotech’s importance to our health, food supply, and national security—were key themes as BIO President & CEO John F.
John Crowley highlights Colorado’s biotech ecosystem during packed Denver tour Read More »
The U.S. bioscience industry generated $3.2 trillion in overall output in 2023, according to the latest report from the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience
U.S. biotech generates $3.2 trillion in a year, report shows Read More »
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, Saol Therapeutics; Margie Battle, Manager, Georgia BioScience Training Center; Megan Heaphy,
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta Read More »
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization (BIO) in recognition of
Virginia Gov. Youngkin named BIO’s Governor of the Year Read More »
In recent years, the number of disruptive, cutting-edge therapies approved or under review by the Food and Drug Administration (FDA) has grown substantially. So-called
Innovative payment arrangements bring transformative therapies from the lab to patients Read More »
Global oncology company BeiGene on July 23 announced the opening of its new flagship U.S. facility in Hopewell, NJ, at the Princeton West Innovation
BeiGene opens new flagship research-manufacturing facility in NJ Read More »
A guest post by Doug Edgeton, president and CEO of the North Carolina Biotechnology Center. We’re marking two big life sciences anniversaries this year
NCBiotech: 40 years of growing North Carolina life sciences Read More »
With the passage of the Inflation Reduction Act (IRA) and the growing number of prescription drug affordability boards (PDABs), patients and the biotech industry
BIO 2024: PDABs and IRA pose a murky threat to patient access Read More »
